isocarboxazid · ISOCARBOXAZID 10 mg/1 · Tablet · Oral · Lifsa Drugs LLC
NDC 72336-0032-01 · 100 TABLET in 1 BOTTLE, PLASTIC · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Lifsa Drugs LLC | ISOCARBOXAZID 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Marplan — NDC 72336-0032-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72336003201.
Free to cite with attribution — see how the data is put together.